Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVSStructural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza VirusAn Insertion Mutation That Distorts Antibody Binding Site Architecture Enhances Function of a Human AntibodyInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 VirusesA recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutininStructure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic siteHuman Rotavirus VP6-Specific Antibodies Mediate Intracellular Neutralization by Binding to a Quaternary Structure in the Transcriptional PoreHuman antibodies that neutralize respiratory droplet transmissible H5N1 influenza virusesAntibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding SiteA potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surfaceProof of principle for epitope-focused vaccine designHost-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing AntibodiesMapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and VaccinationTherapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritisA human antibody against Zika virus crosslinks the E protein to prevent infectionRespiratory syncytial virus induces host RNA stress granules to facilitate viral replicationChallenges and opportunities in developing respiratory syncytial virus therapeuticsInfluenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.H7N9 influenza virus neutralizing antibodies that possess few somatic mutationsSevere pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza virusesRespiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells.Single molecule-sensitive probes for imaging RNA in live cells.Redesigned HIV antibodies exhibit enhanced neutralizing potency and breadth.Evaporative cooling feature selection for genotypic data involving interactionsTowards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools.A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.Capturing the spectrum of interaction effects in genetic association studies by simulated evaporative cooling network analysisCharacterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearanceAmphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.Population-based incidence of human metapneumovirus infection among hospitalized children.The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.
P50
Q24336246-56FB9790-EEA8-4E09-A227-DF2204B12450Q27660330-A6551E8A-D6F3-4701-88C7-87A978EF39BFQ27666908-3BAAA991-4B67-4A19-9459-ECE55CBF7BF4Q27675477-1B24E6A4-3138-4159-926D-5C48F41CA9FCQ27676298-6C8AB360-866F-4E21-98AA-DD83BC9BEE8FQ27677823-BACAED81-52A6-49BC-AE0D-662E2190D799Q27678128-FFE4D3C2-B7B7-4BF1-B814-91E24F1EDE57Q27679859-3788C164-6243-4635-AF94-F54E9B3CA1B9Q27679927-59A208B0-1679-4CBD-9D07-B3708608FAFDQ27681319-9AA9065B-7A28-4E94-87FD-C1CD599DC7A9Q27681593-5D6D3A4F-0FBD-483F-9406-FB65FA76FAA3Q27704173-AA13F20E-CF93-4134-97E9-D4A09532D9E6Q28114614-2AF09CA2-F129-45AD-B604-7531DB2BFF3DQ28656412-21CCFE3A-A171-4641-8D8F-5C557C9668AAQ28950443-3D45DDFD-3EFB-45B1-9E4B-9E646E6329E7Q30156026-DDE49CC3-4911-4C5E-AED2-179E91ADBAB2Q30300567-0FBD2079-B76F-4B11-839E-19A96D5C2A64Q30370985-1AE91E74-941A-4917-A956-B92DAB03178FQ30371529-4C5A7424-1414-4AC3-830F-BE0565C999FFQ30383987-CFB8847C-3F62-46B2-8B06-49960481C9EEQ30385356-93965EDC-7B2B-4075-ADD2-937146DF774CQ30397001-B4751048-1CC3-49B7-A0E7-2E1742B4D693Q30406095-0ED61E8B-4553-4DE2-A673-371B03EECB2BQ30414712-36324582-71C2-4AEB-A256-F9AF97AFAD6AQ30482790-9AD21FF3-CABB-4D4F-AAC6-5B0978B2DFD4Q30570055-E6BB7EA2-168B-4F98-85AF-2465EEC6EDB0Q30616114-97F8F625-C9B8-49E1-B3E9-F05F0F7C2F38Q30657338-E0ED9E74-A970-48C9-8944-FE43611D4F6FQ31116626-1C437D95-63FE-476E-956E-608CD5AF5AECQ33268324-EF81192A-F924-4522-817B-0B68E1BE5044Q33285591-2C0F9C5B-4FDF-415C-A06E-F19AC249B94AQ33419845-1DE15A89-E999-4948-B386-228BDE8B9401Q33431345-18F7BA5E-29F3-4C2D-AD67-E447D0A2B843Q33631104-4572F4FA-AEF7-4320-B03E-44D043B20F8AQ33750475-6D8E515F-30A0-4D91-BB9B-853C27680D4BQ33755041-7C5504CF-7E1B-4F16-8FAD-CBDAE3C08D05Q33775790-24327D03-8DF8-4E00-96A6-1BC48C43AE4BQ33853893-283A8D11-4240-4BCA-9D15-C7B702EE1079Q33862733-ADAD1769-2AEE-4672-A6E4-E48D8E7AD3B8Q33930308-DA41581C-E001-4B1C-9E98-040831F3431D
P50
description
hulumtues
@sq
immunoloog
@nl
pediatrician
@en
հետազոտող
@hy
name
James E. Crowe Jr.
@ast
James E. Crowe Jr.
@en
James E. Crowe Jr.
@es
James E. Crowe Jr.
@nl
James E. Crowe Jr.
@sl
type
label
James E. Crowe Jr.
@ast
James E. Crowe Jr.
@en
James E. Crowe Jr.
@es
James E. Crowe Jr.
@nl
James E. Crowe Jr.
@sl
altLabel
Jim Crowe
@en
Jr. James E. Crowe
@en
prefLabel
James E. Crowe Jr.
@ast
James E. Crowe Jr.
@en
James E. Crowe Jr.
@es
James E. Crowe Jr.
@nl
James E. Crowe Jr.
@sl
P1053
B-5549-2009
P106
P1153
26642993000
P21
P2456
P2798
P31
P3829
P496
0000-0002-0049-1079
P569
1961-08-14T00:00:00Z